Palboheal 125 Palbociclib 125mg Capsules

Palboheal 125 Palbociclib 125mg Capsules Description:
Palboheal 125 capsule -Palbociclib 125mg, a targeted cancer therapy used primarily in the treatment of certain types of breast cancer. Palbociclib is a cyclin-dependent kinase (CDK) 4/6 inhibitor, which works by slowing the growth and spread of cancer cells.

Uses:
Palboheal 125 capsule is prescribed for the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, usually in combination with hormone therapies such as letrozole or fulvestrant.

Side Effects:
Palboheal 125 capsules may cause side effects. Some are common and manageable, while others can be serious and require immediate medical attention.

Common Side Effects:

• Low white blood cell count (neutropenia)
• Fatigue
• Nausea
• Diarrhea
• Hair thinning or loss
• Mouth sores
• Decreased appetite

Serious Side Effects:

• Severe infections due to low white blood cells
• Lung inflammation (pneumonitis)
• Blood clots
• Unusual bleeding or bruising
• Severe allergic reactions

Dosage:
The typical recommended dose is 125mg taken orally once daily for 21 consecutive days, followed by 7 days off (a 28-day cycle). Dosage may be adjusted or paused based on side effects or blood test results. Always follow your doctor’s instructions. It is typically taken once daily, with or without food. It is important to follow the dosage instructions provided by your healthcare provider or pharmacist when taking Palbociclib 125mg. Taking more than the recommended dose of Palbociclib can increase the risk of side effects and may not improve the effectiveness of the medication. Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.